Autoantibodies against adrenal medulla in type 1 and type 2 diabetes mellitus: No evidence for an association with autonomic neuropathy

Journal of Internal Medicine

Volumn 239, Issue 2, 1996, Pages 139-146

  Husebye, E S ^a   Winqvist, O ^a   Sundkvlst, G ^b   Kampe O ^a   Karlsson, F A ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Adrenal medulla; Autoantibodies; Autoimmune diseases; Autonomic neuropathy; Type 1 (insulin dependent) diabetes mellitus; Type 2 (non insulin dependent) diabetes mellitus

Indexed keywords

ADRENAL MEDULLA ANTIBODY; AUTOANTIBODY; UNCLASSIFIED DRUG;

ADRENAL MEDULLA; ADULT; AGED; ARTICLE; AUTOIMMUNITY; AUTONOMIC NEUROPATHY; DIABETES MELLITUS; DIABETIC NEUROPATHY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0030027173     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.423766000.x     Document Type: Article

References (36)

1. Watkins PJ. Clinical observations and experiments in diabetic neuropathy. Diabetologia 1992; 35: 2-11.
2. Dyck PJ, Hansen S, Karnes J, O'Brian P, Yasuda H, Windebank A, Zimmerman B. Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci USA 1985; 82: 2513-17.
3. Gabbay KH, Merola LO, Field RA. Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes. Science 1966; 151: 209-10.
4. Duchen DW, Anjorin A, Watkins PJ, Mackay JD. Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med 1980; 92: 301-3.
5. Brown FM, Zuckerman M, Longway S, Rabinowe SL. Adrenal medullary fibrosis in IDDM of long duration. Diabetes Care 1989; 12: 494-7.
6. Brown FM, Smith AM, Longway S, Rabinowe SL. Adrenal medullitis in type 1 diabetes. J Clin Endocrinol Metabol 1990; 71: 1491-5.
7. Guy RJC, Richards F, Edmonds ME, Watkins PJ. Diabetic autonomic neuropathy and iritis: an association suggesting an immunological cause. Br Med J 1984; 289: 343-5.
8. Gilbey SG, Guy RJC, Jones H, Vergani H, Watkins PJ. Diabetic and autonomic neuropathy: An immunological association? Diabetic Medicine 1986; 3: 241-5.
9. Gilbey SG, Hussain MJ, Watkins PJ, Vergani H. Cell-mediated immunity and symptomatic diabetic neuropathy. Diabetic Medicine 1988; 5: 845-8.
10. Schopfer K, Matter L, Tenschert R, Bauer S, Zuppingar K. Anti-glucagon-cell and anti-adrenal-medullary-cell antibodies in islet-cell-antibody-positive diabetic children. NEJM 1984; 310: 1536-7.
11. Brown FM, Kamalesh M, Adri MNS, Rabinowe SL. Anti-adrenal medullary antibodies in IDDM subjects and subjects at high risk of developing IDDM. Diabetes Care 1988; 11: 30-3.
12. Brown FM, Brink SJ, Freeman R, Rabinowe SL. Anti-sympathetic nervous system autoantibodies. Diminished catecholamines with orthostasis. Diabetes 1989; 38: 938-41.
13. Rabinowe SL, Brown FM, Watts M, Kadrofske MM, Vinik AI. Anti-sympathetic ganglia antibodies und postural blood press-ure in IDDM subjects of varying duration and patients at high risk of developing IDDM. Diabetes Care 1989; 12: 1-6.
14. Sundkvist C., Lind P, Bergström B, Lilja B, Rabinowe SL. Autonomic nerve antibodies and autonomic nerve function in type 1 and type 2 diabetic patients. J Int Med 1991; 229: 505-10.
15. Rabinowe SL, Brown FM, Watts M, Smith AM. Complement-fixing antibodies to sympathetic and parasympathetic tissues in IDDM: autonomic brake index and heart-rate variation. Diabetes Care 1990; 13: 1084-8.
16. Brown FM, Watts M, Rabinowe SL. Aggregation of subclinical autonomic nervous system dysfunction and autoantibodies in families with type I diabetes. Diabetes 1991; 40: 1611-14.
17. Zanone MM, Peakman M, Purewal T, Watkins PJ, Vergani D. Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in type I (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 564-9.
18. Itoh N, Hanafusa T, Katsura H et al. Two types of autoantibodies to adrenal medullary cells in type 1 (insulin-dependent) diabetic patients; prevalence, properties and implications. J Autoimmunity 1991; 4: 807-18.
19. Scherbaum WA, Mosel H, Boehm BO, Hedderich U, Gluck M, Schernthaner G, Bottazzo GF, Pfeiffer EF. Autoantibodies to adrenal medullary and thyroid calcitonin cells in type I diabetes mellitus - a prospective study. J Autoimmunity 1988; 1: 219-30.
20. Sundkvist G, Velloso LA, Kämpe O, Rabinowe SL, Ivarsson SA, Lilja B, Karlsson FA. Glutamic acid decarboxylase antibodies (GAD-ab), autonomic nerve antibodies, and diabetic autonomic neuropathy. Diabetologia 1994; 37: 293-9.
21. Bergström B, Lilja B. Österlin S, Sundkvist G. Autonomic neuropathy in non-insulin-dependent (type 2) diabetes mellitus. Possible influence of obesity. J Intern Med 1990; 227: 57-63.
22. Sundkvist G, Almér L-O, Lilja B. Respiratory influence on heart rate in diabetes mellitus. Br Med J 1979; 1: 924-5.
23. Sundkvist G, Lilja B, Almér L-O. Abnormal diastolic blood pressure and heart rate reactions to tilting in diabetes mellitus. Diabetologia 1980; 19: 433-8.
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye. Anal Biochem 1976; 72: 248-54.
25. Greenberg A, Zinder O, Alfa- and beta-receptor control of catecholamine secretion from isolated adrenal medulla cells. Cell Tissue Res 1982; 226: 655-65.
26. Winqvist O, Karlsson FA, Kämpe O. 21-hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 1992; 339: 1559-62.
27. Kämpe O, Andersson A, Björk E, Hallberg A, Karlsson FA. High glucose stimulation of 64,000-Mr islet cell autoantigen expression. Diabetes 1989; 38: 1326-8.
28. Barzilay J, Warram JH, Rand LI, Pfeifer MA, Krolewski AS. Risk for cardiovascular autonomic neuropathy is associated with the HLA-DR 3/4 phenotype in type 1 diabetes mellitus. Ann Intern Med 1992; 116: 544-9.
29. Srinivasan J, Hays AP, Thomas FP, Sadiq SA, Barth KHM, Liem R, Mena MA, DeYebenes JG, Latov N. Autoantigens in human neuroblastoma cells. J Neuroimmunology 1990; 26: 43-50.
30. Kaufman DL, Erlander MG, Clare-Salzier M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992; 89: 283-92.
31. Tuomi T, Zimmet PZ, Rowley MJ, Serjeanton SW, Mackay IR. Persisting antibodies to glutamic acid decarboxylase in type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy. Diabetologia 1993; 36: 685.
32. Petersen JS, Peakman M, Mathias CJ, Watkins PJ, Dyrberg T, Vergani D. High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomie neuropathy. Diabetes 1994; 43: 1146-51.
33. Banga JP, McGregor AM. Enzymes as targets for autoantibodies in human autoimmune disease: relevance to pathugenesis. Autoimmunity 1991; 9: 177-82.
34. +;-adenosine triphosphatase of the stomach. J Clin Invest 1988; 81: 475-9.
35. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Olesen HR, Camilli PD. Identification of the 64K autoantigen in IDDM as the GABA synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-6.
36. Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kämpe O. Two different cytochrome P450 enzymes arc the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest 1993; 92: 2377-85.